惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

S
SegmentFault 最新的问题
博客园 - 三生石上(FineUI控件)
爱范儿
爱范儿
博客园 - 聂微东
V
Visual Studio Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
M
MIT News - Artificial intelligence
The GitHub Blog
The GitHub Blog
Recent Announcements
Recent Announcements
有赞技术团队
有赞技术团队
L
LangChain Blog
I
InfoQ
T
Tailwind CSS Blog
博客园 - 【当耐特】
V
V2EX
博客园_首页
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
GbyAI
GbyAI
Vercel News
Vercel News
雷峰网
雷峰网
量子位
A
About on SuperTechFans
Martin Fowler
Martin Fowler
H
Help Net Security

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day T...
SA Transcripts · 2026-04-28 · via All Articles on Seeking Alpha

Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day April 22, 2026 10:00 AM EDT

Company Participants

Robert Barrow - CEO & Director
Daniel Karlin - Chief Medical Officer
Matthew Wiley - Chief Commercial Officer
Brandi Roberts - Chief Financial Officer

Conference Call Participants

Brittany Albright
Andrew Penn
Shannon Sarkar
Lin Tsai - Jefferies LLC, Research Division
Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division

Presentation

Robert Barrow
CEO & Director

All right. Well, first of all, I want to thank everyone for coming and joining us here today. It's an incredibly exciting time for us. It's an exciting time for our field, and it's great to see everyone here. Many of you, we have spent a lot of time with over the last 5 years, and you've watched not only as we as an organization, but as the entire field has unfolded and has really built to this point where now the promise of what we've been talking about for a long time is coming to fruition and the degree of visibility we're seeing for our field is really taking shape. So we couldn't be more excited to be here with you today. And again, I want to appreciate all of you for coming here and spending your morning and afternoon with us.

Before we get started, forward-looking statements. We'll be saying things about the future that I refer you to all of our filings and the disclaimers, both here and in our SEC filings. We have a great lineup today and great speakers I'll talk about in a second. I'll be brief and then turn it over to Dan, our CMO. We'll have a Q&A session, both with our panel a little bit. And at the end of the event, there's a QR code here at the bottom, right, and it will show up later. Both for folks who are in the room and online, you can ask questions